Akshay Sood to North America
This is a "connection" page, showing publications Akshay Sood has written about North America.
Connection Strength
0.202
-
Corsi NJ, Stephens A, Finati M, Malchow T, Morrison C, Davis M, Hares K, Corsi MP, Arora S, Chiarelli G, Cirulli GO, Autorino R, Sood A, Rogers C, Abdollah F. Testing the external validity of the POUT III trial (adjuvant platnium-based chemotherapy in upper tract urothelial carcinoma) in a North American cohort. Urol Oncol. 2024 Jun; 42(6):175.e19-175.e25.
Score: 0.059
-
Chiarelli G, Davis M, Stephens A, Cirulli GO, Finati M, Corsi NJ, Sood A, Tinsley S, Carrieri G, Briganti A, Montorsi F, Lughezzani G, Buffi N, Rogers C, Abdollah F. Comparison of patient background between a real-world North American cohort and the G?teborg-2 trial. Int J Urol. 2024 May; 31(5):562-567.
Score: 0.059
-
Rakic N, Sood A, Dalela D, Arora S, Malovana U, Keeley J, Rogers C, Peabody J, Menon M, Abdollah F. A Nationwide Persistent Underutilization of Adjuvant Radiotherapy in North American Prostate Cancer Patients. Clin Genitourin Cancer. 2020 12; 18(6):489-499.e6.
Score: 0.045
-
Abdollah F, Arora S, von Landenberg N, Gild P, Sood A, Dalela D, Trinh QD, Menon M, Rogers C. Testing the external validity of the EORTC randomized trial 30904 comparing overall survival after radical nephrectomy vs nephron-sparing surgery in contemporary North American patients with renal cell cancer. BJU Int. 2018 03; 121(3):345-347.
Score: 0.038